Intervacc
Intervacc is a biotechnology company that develops vaccines based on recombinant proteins for animal health.
Intervacc operates in biotechnology, health care, pharmaceutical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2001.
Intervacc is positioned in biotechnology, health care, pharmaceutical, a segment that rewards a clear, focused offering.
Its base of operations is European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
It is recorded at the Grant stage.
The company reports a headcount in the c_00011_00050 range.
Total disclosed funding stands at about $30M.
| Sector | Biotechnology, Health Care, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2001 |
| Employees | c_00011_00050 |
| Stage | grant |
| Total funding | $30,000,000 |
Website: www.intervacc.se
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account